Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist [PDF]
, 2012 Kazuko Haga +10 more
openalex +1 more source
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort
Allergy, Volume 81, Issue 1, Page 185-196, January 2026.This study identified four clinically distinct asthma clusters. The most severe cluster was characterized by type 2 inflammation and exhibited both large and small airways obstruction, as well as air trapping on CT. Patients in the earlier‐onset cluster exhibited more severe bronchial hyperresponsiveness despite a relatively preserved lung function ...
Pauline J. M. Kuks +18 more
wiley +1 more source
Effects of Muscarinic Antagonists on Experimental Nasal Secretion in Guinea Pigs
, 1991 Hiroyuki Mizuno +5 more
openalex +1 more source
Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study [PDF]
, 2019 Beth Hahn +5 more
openalex +1 more source
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same? [PDF]
Tuberc Respir Dis (Seoul), 2018 Miravitlles M +3 more
europepmc +1 more source
Comparison of the muscarinic antagonist effects of scopolamine and L-687,306
, 2020 Gail Winger +2 more
openalex +2 more sources
State‐dependent regulation of the Kv7.2 channel voltage sensor by QO‐58
British Journal of Pharmacology, Volume 183, Issue 2, Page 333-348, January 2026.Background and Purpose KV7(KCNQ) potassium channels are key modulators of neuronal excitability, and promising targets for development of drugs for epilepsy and pain. We investigated a candidate KV7 drug, QO‐58, which has been previously described but has an unclear mechanism of action.
Richard Kanyo +3 more
wiley +1 more source
Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients [PDF]
, 2009 Guy Joos +7 more
openalex +1 more source